Carvedilol

Carvedilol

Products
Carvedilol
Carvedilol

Information

Therapeutic Area: Cardiovascular systemEU DMF availableUS DMF no. 17060 availableCEP available Indication: Carvedilol is a carbazole derivative acts as anti-hypertensive agent. It is formulated as tablets for oral route of administration. Carvedilol is indicated for the management of essential hypertension. It is also indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction. Is also indicated for the treatment of tachycardiac atrial fibrillation.
Product Categories
  • Generic APIs
    Distribution Areas
    OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
    Supplied From
    Poland
    Polpharma S.A.Polpharma Group. European business partner for pharmaceutical companies worldwide. Diversified business oportunities - API, CDMO, OL, In-licensing - supported by professional services and competencies dedicated to the B2B partners to grow beyond the scale together. We are offering environment for collaboration, support from qualified experts and state-of-the-art facilities. We are actively looking for partners in all of our activity areas - from product development stage, through production and commercial cooperation, to other forms of partnership. Polpharma API

    Log in

    See all the content and easy-to-use features by logging in or registering!